Download Sample
Schedule a Meeting
NA : +1 804 441 9344
sales@towardshealthcare.com
September 2025
The global nuclear medicine software market size is calculated at US$ 895.04 in 2024 million, grew to US$ 975.15 million in 2025, and is projected to reach around US$ 2109.19 million by 2034. The market is expanding at a CAGR of 8.95% between 2025 and 2034.
In China, India, Japan, Australia, and South Korea, accelerating investments in the healthcare system, with enhancements in AI-driven imaging solutions, will assist in the future development of the global nuclear medicine software market. Alongside, the market is experiencing major expansion due to widespread demand for accuracy, efficiency in earlier disease detection, and treatment strategies involved in chronic diseases, like cancer, and other concerns. Tools like PET, SPECT, and hybrid modalities (PET/CT, SPECT/CT) are further boosting imaging interpretation, streamlining workflow, and accelerating patient outcomes in developing hospitals and nuclear medicine pharmacies.
| Table | Scope |
| Market Size in 2025 | USD 975.15 Million |
| Projected Market Size in 2034 | USD 2109.19 Million |
| CAGR (2025 - 2034) | 8.95% |
| Leading Region | North America |
| Market Segmentation | By Modality / Imaging Type, By Functionality / Capabilities, By Deployment Mode, By End-User / Buyer, By Region |
| Top Key Players | GE Healthcare, Siemens Healthineers, Philips Healthcare, MIM Software Inc., Mirada Medical, Hermes Medical Solutions, Canon Medical Systems, Cortech, JPM, Riverain Technologies, VIDA Diagnostics, Subtle Medical, Quantib, Quantitative Insights, 4Dmedical, Invicro, Mirada-DM, MIM Encore, Medis medical imaging, Imalogix |
The nuclear medicine software market consists of specialized software used in nuclear medicine imaging, diagnostics, treatment planning, and workflow management. These include tools for PET, SPECT, and hybrid modalities (PET/CT, SPECT/CT), enabling image acquisition, processing, reconstruction, quantification, visualization, workflow scheduling, reporting, and radiation dosimetry. These solutions help clinicians and technologists achieve accurate diagnosis, better treatment planning, streamlined operations, regulatory compliance, and improved patient outcomes, particularly in oncology, cardiology, and neurology applications.
The market comprises several growth factors, such as technological advancements like AI and ML-powered approaches, and the increasing adoption of theranostics.
In 2025, AI algorithms will assist in automating tasks, enhancing image quality, reducing radiation exposure, and potentially contributing to more precise diagnoses and customized treatment strategies. Siemens Healthineers' AIDAN platform, FlowMotion AI, OncoFreeze AI, and Multiparametric PET Suite AI are certain examples of AI-based platforms that are involved in the overall development of the respective market.
For instance,
Ongoing Strategies and Advancements in Imaging Techniques
In the world, the global nuclear medicine software market possesses continuous developments in imaging techniques, such as SPECT/CT, PET/CT, and theranostics (combined therapy and diagnostics) are fueling novel opportunities for nuclear medicine software. Whereas, the rising involvement of key leaders in strategic initiatives includes consistent product launches with newer and optimized measures to achieve developing clinical requirements. Moreover, emerging strategic alliances and acquisitions support in boosting reach and accelerating technological breakthroughs are also propelling the overall market growth.
Maintenance of Performance and Lack of Trained Personnel
Across the global nuclear medicine software market, arising challenges are the need for continuous updates and maintenance to ensure optimal activity and highlight security vulnerabilities. This ultimately creates a crucial burden for healthcare facilities, mainly in small-scale organizations. As well as a shortage of well-trained personnel in nuclear imaging technologies and data interpretation evolving barrier in the market.
Emerging Novel Approaches with Other Technologies
2025 is a world in which the accelerating use of artificial intelligence and its other relevant tools is widely impacting every sector, including the global nuclear medicine software market. This further gives rise to the integration of AI with nuclear medicine to get highly resolved image quality, automated image analysis, and enhanced disease detection. Furthermore, it comprises the application of AI algorithms in image reconstruction, denoising, and segmentation. Besides this, in the future, the respective market will have chances to explore novel platforms by coupling with other highly sophisticated technologies, especially with PACS (Picture Archiving and Communication Systems), which has various features of workflow orchestration, and mobile accessibility with raised alliance and effectiveness.
In 2024, the PET (Positron Emission Tomography) software segment captured the biggest revenue share of the market. The segment is driven by growing advances in this software area, like the transforming of high-sensitivity total-body scanners, which are escalating scan speed, decreasing radiation exposure, and evolving the scope of PET imaging. Moreover, PET software has widespread applications, with enhanced emphasis on functional imaging and disease diagnosis in numerous domains, such as oncology, neurology, and cardiology. In these areas, PET boosts prior disease detection, staging, treatment planning, and monitoring.
Whereas the quantitative nuclear medicine segment is predicted to register the fastest growth. Mainly, the emergence of SUV calculation, kinetic modeling is assisting in driving this segment's development. This segment encompasses the utilization of imaging data to obtain numerical values that demonstrate physiological processes, coupled with diagnosis, treatment planning, and monitoring. Additionally, QNM offers objective, numerical data with minimized subjectivity in image analysis. Alongside, to enhance image quality, QNM software-derived tools are employed in image reconstruction, artifact reduction, and image improvement, which are essential for accurate quantification.
In the global nuclear medicine software market, the image reconstruction & processing segment registered dominance with a major share. The segment is fueled by involvement techniques, such as scatter correction and resolution recovery are being unified into iterative reconstruction algorithms to further progress image quality. Apart from this, the participation of quicker processors and enhanced computing capacity is allowing the utilization of more complex and computationally rigorous algorithms in clinical settings.
The AI-powered diagnostics & decision support segment will expand rapidly in 2025-2034. AI has numerous advantages in the market; likewise, it supports improving image quality, reducing noise, and also optimizes the interpretation of difficult data in cardiac imaging and oncology. As AI-driven tools have wide-ranging capabilities in raising accuracy, they are widely adopted in the automated detection and delineation of lesions in nuclear medicine images. Along with this, they further assist in the quantification of tracer uptake in specific organs or tissues, which are necessary for examining disease severity and treatment response.
The on-premises/installed software segment led with the biggest share of the global nuclear medicine software market in 2024. The increasingly heavy investments in on-premises infrastructures are mainly impacting this segment’s growth. This advanced infrastructure further helps in managing issues regarding data security, privacy regulations, such as HIPAA and GDPR, with greater protection of patients’ sensitive data. In addition, this kind of deployment mode manages patient scheduling, radio-pharmacy management, film library operations, report generation, quality assurance, and inventory control.
Although the cloud-based/SaaS solutions segment is anticipated to witness growth at the fastest CAGR, these solutions provide the omission of major investments in hardware and software is propelling the segment expansion. Along with affordability, another advantage is its scalability, which enables easily adjust their resources based on the requirements. Also, cloud-native PACS platforms, mainly Sectra's Cloud Imaging Platform and Intelerad's IntelePACS Cloud, can be integrated with AI modules to obtain automated image analysis and reporting. This further accelerates support for different nuclear medicine procedures, especially PET/CT, SPECT/CT, and general nuclear medicine imaging.
By end-user/buyer, the hospitals & health systems segment registered dominance in the market. A rise in a huge number of nuclear medicine procedures in hospitals and health systems, consisting of various diagnostics and therapeutic applications, is generating a significant demand for robust and trustworthy software. As well as hospitals are surrounded by specialized personnel and resources are also boosting the overall market development. Besides this, integration of this software with other systems, like hospital information systems (HIS), radiology information systems (RIS), and picture archiving and communication systems (PACS), is driving this segment expansion.
On the other hand, the nuclear pharmacy/theranostics facilities segment will grow rapidly. Nowadays, the growing use of AI and advanced analytics is boosting diagnostic precision, automating workflows, and optimizing the interpretation of complex imaging data is supporting the adoption of nuclear medicine software in these areas. However, an immense application of this software is playing a vital role in allowing tailored treatment plans by offering meaningful and deeper imaging and patient data for customized therapy plans. Also, stepping into cloud-based PACS and remotely accessible solutions escalates access to advanced nuclear medicine software and facilitates collaboration among healthcare professionals.
In the nuclear medicine software market, North America accounted for the largest revenue share in 2024. Primarily involved driver in this region’s market expansion is the well-developed and advanced healthcare system of this region, with the adoption of imaging technologies. As well as this region is increasingly facilitating quantitative imaging, to allow accurate measurement of physiological parameters and customizing treatments to each patient.
For this market,
The US is experiencing crucial growth in the nuclear medicine software market, due to the increasing usage of a combination of diagnostics and therapeutics is supporting the selection of patients for targeted therapies based on their imaging results. Moreover, this region is emphasizing a movement towards the adoption of subscription-based SaaS models because of their minimal investment, flexibility, and cloud-based deployment benefits, particularly for multi-site imaging networks.
In Canada, the contribution of key market leaders in the wider adoption of nuclear medicine software is propelling the progression of the nuclear medicine software market. Besides this, this region is focusing on increased adoption of subscription-based software-as-a-service (SaaS) models with their important benefits like inexpensiveness, flexibility, and measurability.
For instance,
The nuclear medicine software market is experiencing rapid expansion in the Asia Pacific due to the rising focus of different ASAP countries, such as China, India, Japan, Australia, and South Korea, on the development of their healthcare systems. This further expands the advancements in healthcare infrastructure with the broader adoption of AI-powered imaging measures. Likewise, ASAP has incorporated newer software applications in the diagnostic area, particularly in image acquisition, reconstruction, quantification, and automated interpretation, which are assisting the market growth.
China has been playing a major role in the ongoing technological breakthroughs involved in the nuclear medicine software market. China is mainly emphasizing SPECT and PET, coupled with the integration of artificial intelligence and machine learning, which ultimately helps in expanding diagnostic and other healthcare areas.
For this market,
Widespread emergence of many South Korean market players is boosting the enormous dependence on cloud-based platforms with convenient data sharing. In this region, the growing application of integrated approaches with other hospital information systems (HIS) and picture archiving and communication systems (PACS) for simplified workflows is also influencing the nuclear medicine software market.
For instance,
In Europe, the market is experiencing notable expansion in the market, due to accelerating, consistent initiatives in nuclear medicine software. Primarily, the European Association of Nuclear Medicine is assisting in the advancements in nuclear medicine in Europe through education, research, and policy recommendations. Alongside, the Joint Research Center is putting efforts to bring stakeholders together to resolve limitations relevant to nuclear medicine, like a lack of skills and regulatory barriers.
Germany’s nuclear medicine software market possesses a large pool of the geriatric population, which is widely prone to many diseases, which further raises demand for advanced nuclear medicine diagnosis and treatment. The German government is fostering research and development, as well as cancer screening programs, which are fueling overall market progress.
For this market,
Continuous innovations involved in AI, cloud computing, and advanced analytics are elevating imaging accuracy, workflow effectiveness, and treatment planning, is ultimately impacts the nuclear medicine software market in the UK.
By Modality / Imaging Type
By Functionality / Capabilities
By Deployment Mode
By End-User / Buyer
By Region
September 2025
September 2025
September 2025
September 2025